<DOC>
<DOCNO>EP-0646598</DOCNO> 
<TEXT>
<INVENTION-TITLE>
New pseudopeptides with antiviral activity containing valine.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3800	A61K3800	A61P3100	A61P3112	C07D20900	C07D20942	C07D21300	C07D21330	C07D21356	C07D21370	C07D21500	C07D21514	C07D21548	C07D24100	C07D24124	C07D24146	C07D24900	C07D24906	C07K100	C07K1113	C07K500	C07K5068	C07K5072	C07K509	C07K5097	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07K	C07K	C07K	C07K	C07K	C07K	C07K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61K38	A61P31	A61P31	C07D209	C07D209	C07D213	C07D213	C07D213	C07D213	C07D215	C07D215	C07D215	C07D241	C07D241	C07D241	C07D249	C07D249	C07K1	C07K1	C07K5	C07K5	C07K5	C07K5	C07K5	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to pseudopeptides with valine-containing substituents and the general formula (I) 
<
IMAGE
>
 in which the substituents have the meaning stated in the description, a process for the preparation thereof and the use thereof as antiviral agents, especially against cytomegaloviruses.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
</TEXT>
</DOC>
